Tag: myeloma breakthrough
-
FDA Approves Darzalex Faspro as Part of a New First‑Line Quadruplet Regimen for Multiple Myeloma
Multiple myeloma is a type of blood cancer that affects plasma cells – specialized white blood cells that help the body fight infections. For years, treatment options have steadily improved, but the newest development marks one of the most meaningful steps forward yet. The U.S. Food and Drug Administration (FDA) has approved a new four‑drug